Plasma Electrolytic Oxide Coating with Silver Nanoparticles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibacterial coatings for medical implants, such as those using silver, face challenges including high production costs, energy consumption, difficulty in coating complex surfaces, potential for silver toxicity, and resistance development by bacteria, while also needing to promote tissue ingrowth and be cost-effective.
Innovation Solution
A method involving plasma electrolytic oxidation (PEO) to create a nanoSilver or nanoapatite coating on medical devices using a colloid-dispersed system, where AC voltage is applied to form a porous oxide film with silver or apatite particles, allowing for controlled antibacterial efficacy and biocompatibility, and the ability to coat complex surfaces efficiently.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PVD and PECVD processes are used to apply silver coating, then reliable antibacterial protection is achieved, but production cost increases and energy consumption increases
Solution Approach 1:
The patent replaces expensive PVD/PECVD equipment with a simple dip-coating apparatus using colloidal silver suspension. The coating process uses low-cost materials (silver colloids, binding agents) and requires no vacuum systems, dramatically reducing capital investment and operational costs while maintaining antibacterial efficacy.
Solution Approach 2:
The patent substitutes complex mechanical vacuum deposition systems with a chemical/colloidal deposition method. Instead of physical vapor deposition requiring vacuum chambers, the invention uses dip-coating where silver colloids naturally deposit onto the implant surface through capillary action and adhesion, eliminating expensive mechanical systems.
2Reliability
If PVD technique is used to apply silver coating, then antibacterial coating is formed, but coating of complex surfaces becomes difficult
Solution Approach 1:
The dip-coating method with colloidal suspension is universally applicable to any surface geometry. The liquid colloid penetrates complex structures, conformal coatings, porous surfaces, and irregular shapes equally well, making the process adaptable to diverse implant types (screws, plates, joints, catheters) without requiring tooling changes.
Solution Approach 2:
The patent utilizes fluid dynamics principles where the colloidal silver suspension, as a liquid, naturally flows into and coats complex surface geometries through capillary action and hydrodynamic forces during immersion and withdrawal, achieving uniform coverage on any surface shape without line-of-sight limitations.
3Reliability
If high concentration of silver is used in coating, then antibacterial efficacy increases, but risk of silver toxicity increases
Solution Approach 1:
The patent creates a localized high-concentration silver reservoir at the coating surface for maximum antibacterial effect, while the binding agent matrix controls the release rate to prevent systemic toxicity. The colloidal structure provides high surface area silver exposure locally, but the binding agent moderates bulk release to safe levels.
Solution Approach 2:
The binding agent provides controlled, periodic release of silver ions from the colloid suspension. Instead of immediate high-dose release causing toxicity, the silver is released gradually over time through diffusion and ionization, maintaining effective antibacterial concentrations at the surface while keeping systemic exposure below toxic thresholds.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a high antimicrobial efficacy with reduced risk of toxicity, promotes tissue integration, and is cost-effective, with the ability to coat any surface shape, providing a stable and effective antibacterial barrier against multi-resistant strains.
Implementation Method 1
converting the immersed surface to an oxide film by plasma electrolytic oxidation
Implementation Method 2
generating an AC voltage difference between the medical device as a first electrode and a second electrode positioned in the colloid-dispersed system to convert the immersed surface to an oxide film by plasma electrolytic oxidation
Data Source
Figure 1a
Figure 1b~1d
Figure 1e
AI summary
The present invention relates generally to an antibacterial coating which is composed of silver, to medical tools and to implants comprising such a coating and to a method as well to an apparatus for the production of such a coating. The medical tools or the dental or orthopaedic implant comprises a metal or metal alloy having a treated surface wherein the treated surface is at least partially converted to an oxide film by plasma electrolytic oxidation using a colloid-dispersed system and wherein the converted surface is partially covered by islands formed by colloid-dispersed silver-particles of the colloid-dispersed system. An Ag-TiO2 coating according to the invention shows excellent properties in terms of antibacterial efficacy (even against multi-resistant strains), adhesion and biocompatibility. The life-time of an implant in a human body is increased. The antibacterial coating can be used in the field of traumatology, orthopaedic, osteosynthesis and/or endoprothesis, especially where high infection risk exists. A high number of currently existing medical tools and implants can benefit from such a coating.